Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.670
-0.085 (-1.79%)
Jul 11, 2025, 5:29 PM CET

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had revenue of 12.70M SEK in the quarter ending March 31, 2025, with 4.96% growth. This brings the company's revenue in the last twelve months to 46.70M, down -25.76% year-over-year. In the year 2024, Egetis Therapeutics AB had annual revenue of 46.10M, down -19.97%.

Revenue (ttm)
46.70M
Revenue Growth
-25.76%
P/S Ratio
36.58
Revenue / Employee
1.23M
Employees
40
Market Cap
1.71B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 46.10M -11.50M -19.97%
Dec 31, 2023 57.60M 35.00M 154.87%
Dec 31, 2022 22.60M -15.60M -40.84%
Dec 31, 2021 38.20M -2.46M -6.05%
Dec 31, 2020 40.66M -41.90M -50.75%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.31B
Getinge AB 35.57B
Asker Healthcare Group AB 15.57B
Camurus AB 2.04B
Medicover AB 23.56B
AddLife AB 10.42B
Vimian Group AB 4.24B
Revenue Rankings